Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation

Pediatr Neurol. 1996 Oct;15(3):237-9. doi: 10.1016/s0887-8994(96)00164-6.

Abstract

A 4-year-old child with metachromatic leukodystrophy was initially diagnosed with chronic immune demyelinating polyneuropathy and treated with immunosuppressive therapy. Physical examination revealed diffuse, distal > proximal weakness and areflexia. Electro-diagnostic studies revealed nerve conduction velocities that were slowed to variable degrees in different nerves. In the 18 months after institution of immunomodulating therapy, she had functionally significant improvement and a quantitative increase in her strength. Treatment was discontinued at age 6 years when the patient developed urinary incontinence, followed by loss of motor and cognitive skills. We conclude that immunomodulation early in the course of metachromatic leukodystrophy presenting as a neuropathy may result in temporary functional improvement. Whether the immunomodulation altered the disease progression or had direct effects on the function of the dysmyelinated axons is not known.

Publication types

  • Case Reports

MeSH terms

  • Azathioprine / therapeutic use*
  • Child, Preschool
  • Cyclosporine / therapeutic use*
  • Female
  • Humans
  • Immunization, Passive*
  • Immunosuppressive Agents / therapeutic use*
  • Leukodystrophy, Metachromatic / diagnosis
  • Leukodystrophy, Metachromatic / therapy*
  • Neural Conduction

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine